The main mechanisms and strategies of HCC combination therapy
<Hepatology Digest>: What is the specific efficacy of combination therapies in improving tumor response in HCC, and how can the optimal treatment combinations and timing be determined?
The focus of scientific research in MASLD
<Hepatology Digest>: What are the current research focuses on metabolic-associated fatty liver disease? What are the key scientific questions that need further exploration?
What new concepts and methods have gut microbiome research brought to the diagnosis and treatment of autoimmune liver disease?
<Hepatology Digest>: How can studying the microbiome provide new insights and methods for the diagnosis, prevention, and treatment of autoimmune liver diseases?
How to improve HCV screening?
<Hepatology Digest>: Which populations should priority be given for HCV screening, and how can we improve screening rates to ensure early detection and treatment?
The main highlights of 2023 AASLD Annual Meeting
<Hepatology Digest>: What are the main highlights of this Annual Meeting? Is it very different from the previous two ones？
How can patients perceive and actively manage MASLD on their own?
<Hepatology Digest>: How can patients perceive and actively manage MASLD on their own to alleviate the condition and avoid further deterioration?
Current treatment status and challenges for intermediate and advanced stage HCC
<Hepatology Digest>: What is the efficacy of current treatment strategies for intermediate and advanced stage HCC, and what are the challenges and limitations associated with them?
The mechanism of tumor microenvironment affecting the occurrence and development of HCC
<Hepatology Digest>: How does the tumor immune microenvironment affect the efficacy of precision HCC therapy?
The worldwide prevalence trend of MASLD
<Hepatology Digest>: What is the prevalence trend of MASLD globally? Are there specific regions or populations that are more affected and why?
What is the association between the microbiome and autoimmune liver diseases?
<Hepatology Digest>: What role does microbiomics play in the pathogenesis of autoimmune liver diseases? What current research findings have revealed the association between the microbiome and autoimmune liver diseases?